阿尔蒂维昂 AORT
$20.21 −$5.12 (-20.21%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $20.21 0.00%
开盘$22.19
昨收$25.33
当日区间$19.74 – $23.01
成交量3.25M
市值$986.05M
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例97.5%+1.23 个百分点，较上季度
持仓机构数261+4 ，较上季度
内部人近期交易20次买入 / 28次卖出净卖出
空头持仓比例7.66% 占流通股回补天数 7.2 · 截至 15 Oct 2026
卖空成交量占比18.9%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$2.51M（2个净流入日，18个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有34.9%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从5.57%升至7.66%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| BlackRock | Mutual Fund | 2026/Q3 | +485,262 | 14.7% |
| Ophir Asset Management Pty Ltd | Mutual Fund | 2026/Q3 | +849,158 | 3.7% |
| Juniper Investment Company, LLC | Hedge Fund | 2026/Q3 | +830,749 | 4.1% |
| Citadel Advisors LLC | Hedge Fund | 2026/Q3 | +756,725 | 1.7% |
| Macquarie Investment Management Business Trust | Mutual Fund | 2026/Q3 | +728,828 | 6.5% |
| Conestoga Capital Advisors, LLC | Mutual Fund | 2026/Q3 | +448,290 | 3.3% |
| D. E. Shaw & Co., L.P. | Hedge Fund | 2026/Q3 | +431,690 | 0.9% |
| Soleus Capital Management, L.P. | Hedge Fund | 2026/Q3 | +388,000 | 0.8% |
| Silvercrest Asset Management Group LLC | Mutual Fund | 2026/Q3 | +363,150 | 2.1% |
| Balyasny Asset Management L.P. | Hedge Fund | 2026/Q3 | +352,496 | 0.8% |
| Qube Research & Technologies Ltd | Mutual Fund | 2026/Q3 | +275,082 | 1.0% |
| Morgan Stanley | Public Company | 2026/Q3 | +228,765 | 4.8% |
| Delaware Management Company | Mutual Fund | 2026/Q3 | +226,288 | 1.1% |
| Royce & Associates, LP | Mutual Fund | 2026/Q3 | +214,000 | 1.3% |
| BlackRock | Mutual Fund | 2026/Q3 | +199,163 | 13.7% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 9 Sep 2026 | Andrew Green | Senior Vice President of Regulatory & Quality | Open Market Disposition | -11,480 | $24.97 | 40,160 |
| 2 Sep 2026 | Andrew Green | Senior Vice President of Regulatory & Quality | Intent to Sell (Form 144) | -1,493 | $26.02 | – |
| 2 Sep 2026 | Andrew Green | Senior Vice President of Regulatory & Quality | Open Market Disposition | -8,003 | $27.27 | 51,640 |
| 1 Sep 2026 | Andrew Green | Senior Vice President of Regulatory & Quality | Intent to Sell (Form 144) | -6,510 | $27.27 | – |
| 26 Aug 2026 | Marshall Stanton | Former Senior VP of Clinical Research & Chief Medical Officer | Intent to Sell (Form 144) | -7,400 | $26.85 | – |
| 18 Aug 2026 | James Mackin | Chairperson & CEO | Open Market Disposition | -70,000 | $28.96 | 877,275 |
| 13 Aug 2026 | Andrew Green | Senior Vice President of Regulatory & Quality | Open Market Disposition | -616 | $28.55 | 59,643 |
| 13 Aug 2026 | Lance Berry | EVP, COO, CFO & Treasurer | Open Market Disposition | -715 | $28.55 | 210,112 |
| 11 Aug 2026 | Jean Holloway | Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary | Open Market Disposition | -977 | $28.49 | 184,118 |
| 10 Jun 2026 | Andrew Green | Senior Vice President of Regulatory & Quality | Derivative Exercise and Sale | -44,001 | $20.71 | 60,259 |
| 1 Jun 2026 | Anthony Semedo | Independent Director | Other Acquisition | +6,325 | – | 47,560 |
| 1 Jun 2026 | Anthony Semedo | Independent Director | Other Disposition | -6,325 | – | 47,560 |
| 31 May 2026 | Andrew Green | Senior Vice President of Regulatory & Quality | Initial Statement of Beneficial | +0 | – | 44,001 |
| 17 May 2026 | James Bullock | Independent Director | Other Acquisition | +7,576 | – | 76,223 |
| 17 May 2026 | Thomas Ackerman | Independent Director | Other Acquisition | +7,576 | – | 157,472 |
| 17 May 2026 | Anthony Semedo | Independent Director | Other Acquisition | +7,576 | – | 46,960 |
| 17 May 2026 | Daniel Bevevino | Independent Director | Other Acquisition | +7,576 | – | 157,637 |
| 17 May 2026 | Jeffrey Burbank | Independent Director | Other Acquisition | +7,576 | – | 61,372 |
| 17 May 2026 | Jon Salveson | Independent Director | Other Acquisition | +7,576 | – | 137,416 |
| 17 May 2026 | Marna Borgstrom | Independent Director | Other Acquisition | +7,576 | – | 56,664 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 3,735,523 | 7.7% | 7.2 |
| 30 Sep 2026 | 3,621,461 | 7.4% | 5.5 |
| 15 Sep 2026 | 3,284,198 | 6.7% | 5.4 |
| 31 Aug 2026 | 2,927,038 | 6.0% | 4.4 |
| 14 Aug 2026 | 2,745,747 | 5.6% | 3.2 |
| 31 Jul 2026 | 2,705,501 | 5.6% | 4.8 |
暂无评论——快来第一个聊聊 AORT。